Prednisolone clearance at steady state in dogs
- PMID: 7441495
Prednisolone clearance at steady state in dogs
Abstract
The purposes of this study were: 1) to determine in dogs under steady-state conditions whether prednisolone clearance increases with increasing dose as has been suggested from results obtained under nonsteady-state conditions in man and 2) to determine whether the prednisolone to prednisone conversion, apparently resulting from 11 beta-hydroxydehydrogenase, is saturable. Six dogs were given four different zero-order infusions of prednisolone resulting in steady-state levels from 23 to 5884 ng/ml.Prednisone, total and free prednisolone levels were assessed by high-pressure liquid chromatography and equilibrium dialysis. Total and unbound prednisolone clearances were calculated by dividing the infusion rate by the total or unbound prednisolone concentration at steady state. Both total and unbound prednisolone clearance exhibited a slight tendency to decrease (P < .05) with increasing prednisolone steady-state levels. The conversion of prednisolone to prednisone, defined by the prednisolone/prednisone ratio, exhibited saturable characteristics which, when data for all dogs was fitted to a Michaelis-Menten type equation (r2 = 0.938), gave a Km of 658 ng/ml, i.e., total prednisolone concentration at half-maximal saturation.
Similar articles
-
Tissue distribution of prednisolone in the rabbit.J Pharmacol Exp Ther. 1984 Jun;229(3):719-25. J Pharmacol Exp Ther. 1984. PMID: 6726655
-
Prednisolone clearance at steady state in man.J Clin Endocrinol Metab. 1982 Oct;55(4):762-7. doi: 10.1210/jcem-55-4-762. J Clin Endocrinol Metab. 1982. PMID: 7107818
-
Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.Drug Metab Dispos. 1985 Jul-Aug;13(4):503-9. Drug Metab Dispos. 1985. PMID: 2863117
-
Monitoring prednisone and prednisolone.Ther Drug Monit. 1980;2(2):169-76. doi: 10.1097/00007691-198004000-00011. Ther Drug Monit. 1980. PMID: 6762710 Review.
-
Clinical pharmacokinetics of prednisone and prednisolone.Clin Pharmacokinet. 1990 Aug;19(2):126-46. doi: 10.2165/00003088-199019020-00003. Clin Pharmacokinet. 1990. PMID: 2199128 Review.
Cited by
-
Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.J Pharmacokinet Biopharm. 1986 Oct;14(5):453-67. doi: 10.1007/BF01059655. J Pharmacokinet Biopharm. 1986. PMID: 3806371
-
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.Cell Mol Immunol. 2017 Feb;14(2):146-179. doi: 10.1038/cmi.2016.39. Epub 2016 Oct 10. Cell Mol Immunol. 2017. PMID: 27721455 Free PMC article. Review.
-
Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients.Eur J Clin Pharmacol. 1981;21(3):235-42. doi: 10.1007/BF00627926. Eur J Clin Pharmacol. 1981. PMID: 7032949 Clinical Trial. No abstract available.
-
Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.J Pharmacokinet Biopharm. 1990 Oct;18(5):401-21. doi: 10.1007/BF01061702. J Pharmacokinet Biopharm. 1990. PMID: 2266496
-
The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.Br J Clin Pharmacol. 1986 Feb;21(2):183-9. doi: 10.1111/j.1365-2125.1986.tb05173.x. Br J Clin Pharmacol. 1986. PMID: 3954934 Free PMC article.